34 results
6-K
EX-99.2
SPRC
SciSparc Ltd
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
of $60,000 in wages and related expenses, offset by a decrease of $204,000 in chemistry and formulations.
General and Administrative Expenses
Our general … of $2.2 million, offset in part by the increase in net loss of $2.2 million.
Investing Activities
Net cash used in investing activities was $708,000
6-K
EX-99.2
SPRC
SciSparc Ltd
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
expenses, offset in part by an increase of $366 thousand in operating expenses of the Wellution™ brand consisting primarily of advertising expenses … was primarily due to a change in the fair value of the warrants we issued in June 2022, offset by impairment of financial assets. Changes in the fair value
6-K
EX-99.2
SPRC
SciSparc Ltd
16 Aug 21
Interim Consolidated Financial Statements
12:00am
studies, and an increase of $48,000 in clinical studies, offset by a decrease of $83,000 in share-based payments.
General and Administrative Expenses … and business expenses and an increase of $0.2 million in professional and director fees, offset by a decrease of $0.06 million in share-based payments
6-K
EX-99.2
SPRC
SciSparc Ltd
9 Oct 20
Interim Consolidated Financial Statements
12:00am
, reflecting the ending of clinical and preclinical studies that were ended in previous year and a decrease in chemistry & formulations expenses offset … offset by a decrease in working capital adjustments for the six months ended June 30, 2019.
Investing Activities
Net cash used in investing
6-K
EX-99.1
SPRC
SciSparc Ltd
1 Jul 22
Current report (foreign)
4:00pm
hereof, pay the Company $212,766.00. Payment shall be made by wire transfer in immediately available funds without counterclaim, offset or deduction
6-K
ojubee8h296qdurqxvh
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
EX-99.1
lgj9n7revun63h0c8lf
28 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
6:27am
20-F/A
lfxj6upnwtiw
2 May 24
Annual report (foreign) (amended)
9:18am
6-K
EX-4.1
5mms0i3qxbywh9y
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
EX-99.1
j57omze jgj556
9 Oct 20
Interim Consolidated Financial Statements
12:00am
6-K
EX-99.1
8qgml006nbs
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
6-K
EX-99.3
9rtc eknj2izh
2 Mar 21
Report of Foreign Private Issuer
4:05pm
425
tf26pt91ase
2 May 24
Business combination disclosure
4:46pm
F-1
oqd40cta4n4t
27 Feb 24
Registration statement (foreign)
4:15pm
POS AM
q1mnv8
2 May 24
Prospectus update (post-effective amendment)
5:17pm
6-K
EX-10.1
ri6 hn8hz15ntn
12 Oct 23
SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
8:48am